Japan: Precision Resin Molding Group Seeking Medical Device Manufacturers in Japan & ASEAN
JP-B-939

Japan: Precision Resin Molding Group Seeking Medical Device Manufacturers in Japan & ASEAN

Range$1.9M - $3.16M USD
Target BusinessOther Manufacturing · Chemicals & Materials Manufacturing · Healthcare & Medical Services · Automotive & Transport Equipment Manufacturing
Target CountryJapan, Philippines, Thailand
Purpose of M&AStrategic Expansion / Vertical Capability Growth
Budget$1.9M - $3.16M USD
ConditionMajority (51–99%) / Full Acquisition (100%)

Request Full Investor Profile for #JP-B-939

Investor Profile

The investor is an established Japanese precision resin molding and plastics engineering manufacturer with deep technical expertise across high-tolerance injection molding, tooling, and quality-controlled production environments. Backed by a stable domestic manufacturing base and operational familiarity with Southeast Asian production hubs, the acquirer is now pursuing a focused buy-and-build strategy to expand its medical device manufacturing footprint. Strategic Objective: The acquirer seeks control positions in companies primarily engaged in the manufacture of medical devices and medical components using resin molding technologies. Selected automotive-related molding businesses will also be considered where technology, customer base, or capacity offers clear synergy. Transaction Approach: The investor requires majority ownership of more than 51%, with a strong preference for 100% acquisition. Importantly, the acquirer intends for incumbent management to remain in place post-closing, offering continuity for employees, customers, and certifications rather than disruptive restructuring. Geographic Focus: Japan, the Philippines, and Thailand — markets in which the investor already possesses operational knowledge, supplier networks, and regulatory familiarity. Value to Sellers: Targets gain access to proven molding engineering know-how, cross-border manufacturing capacity, procurement scale, and a committed long-term industrial owner rather than a short-horizon financial buyer. This mandate is particularly suited to owner-managers seeking succession solutions while preserving the company's identity, workforce, and technical heritage. Mandate strength is rated at the highest internal tier, with funding secured and the ability to execute swiftly on qualified opportunities.

Investor profile — JP-B-939

Create a free account to unlock the full investor profile and continue exploring this opportunity.

Sign up to save this profile, access downloadable materials, and receive updates on relevant investment opportunities.

Want more information first? Talk with us and we'll gladly walk you through the opportunity before you sign up.

Other Investors for You

View All Investors
Japan: Leading Sushi Restaurant Operator Seeking Global Franchise & 100% Acquisition Partners
North AmericaNorth America + 4
#JP-B-862

Japan: Leading Sushi Restaurant Operator Seeking Global Franchise & 100% Acquisition Partners

The investor is a prominent Japanese multi-unit sushi restaurant operator with a proven, highly systemised brick-and-mortar dining format and deep expertise in seafood sourcing, quality control, kitchen automation and unit economics. Building on an established domestic footprint and successful overseas franchising track record, the acquirer is now pursuing an accelerated international expansion programme. Strategic objective: to secure capable local partners and platform businesses across North America, Europe, the Middle East, South Korea and Taiwan. Southeast Asia is expressly excluded, as an existing franchise partner already covers that territory. Transaction appetite is flexible: the investor will consider master franchise or area development agreements as well as full 100% acquisitions of existing restaurant operators, multi-site food service groups, or complementary hospitality platforms that can be converted or integrated into its format. A capital commitment of up to approximately JPY 5 billion is available per opportunity, supported by a strong balance sheet and rapid internal decision-making. Ideal targets include restaurant chains, casual dining and food-court operators, quality food service groups with prime real estate access, and experienced operating teams with local licensing, supply chain and recruitment capability. Cold-chain logistics and seafood distribution assets are also of interest as enablers. Value offered to counterparties: a globally recognised Japanese culinary category, turnkey operating manuals, training academies, proprietary equipment and technology, procurement scale, and long-term brand stewardship. Management continuity and employee retention are welcomed. All discussions are conducted on a strictly confidential basis.

Learn More
Japan: Listed Aesthetic Medical Group Seeking APAC Clinic & Healthcare Acquisitions
Asia-Pacific + 3
#JP-B-827

Japan: Listed Aesthetic Medical Group Seeking APAC Clinic & Healthcare Acquisitions

The investor is a publicly listed Japanese healthcare group operating one of Asia's most recognised aesthetic and cosmetic medical platforms. Built on a highly scalable clinic management model, the acquirer provides member clinics with branding, patient acquisition, procurement, physician training, digital systems and operational know-how — a proven infrastructure that has supported rapid, high-margin network growth in its domestic market. The group has recently established a dedicated Asia-Pacific headquarters to serve as its strategic hub for market analysis, new business development and partnership formation across the region. Through this platform, the investor intends to export Japan's high-standard aesthetic medicine to APAC markets, accelerating local clinic rollout and brand penetration. Acquisition appetite focuses on: aesthetic, dermatology, dental and specialty clinic groups; medical device distribution and cosmetics/skincare brands; clinic management and healthcare SaaS platforms; and adjacent wellness or personal-care service businesses with strong local licensing and talent. The investor is flexible on structure, considering minority stakes, majority control or full acquisition, with a budget range of approximately JPY 100 million to JPY 2 billion. Beyond capital, the acquirer offers sellers access to a mature operating playbook, cross-border patient flow, established supplier economics, physician training programmes and the credibility of a listed parent — enabling founders to scale far beyond organic capacity while preserving clinical identity. Management continuity is welcomed, and transaction timelines can be expedited for well-governed targets.

Learn More
Japan: Listed HR & Staffing Group Seeking Apparel Manufacturing and Overseas Talent-Sending Agencies
Asia (incl. ASEAN + 1
#JP-B-519

Japan: Listed HR & Staffing Group Seeking Apparel Manufacturing and Overseas Talent-Sending Agencies

The investor is a well-capitalised Japanese group with a strong track record in human resources, staffing and workforce solutions. Backed by stable earnings and an established domestic platform, the acquirer is now pursuing a clearly defined cross-border growth agenda and has been assigned an 'A' mandate strength, reflecting high execution readiness and immediate capacity to review opportunities. Strategic focus areas: 1. Apparel & Textile Manufacturing — garment and apparel production operations, including OEM/ODM factories. The investor confirms that apparel manufacturing targets can be reviewed immediately, with rapid internal decision-making. 2. Human Resources & Talent Mobility — overseas sending organisations, dispatch agencies, technical intern and specified-skilled-worker recruitment platforms that channel talent into the Japanese labour market, alongside adjacent training and placement businesses. Value offered to target shareholders: access to an established Japanese client network and corporate demand pipeline, governance and compliance frameworks aligned with listed-company standards, sustained growth capital, and long-term partnership rather than short-hold financial ownership. Existing management teams and founders are encouraged to remain in place, with flexible deal structuring available. Transaction parameters: the acquirer will consider minority stakes below 50% as well as majority positions of 51–99%, with an investment envelope of approximately JPY 100 million to JPY 1 billion. Both phased acquisitions and outright controlling investments can be accommodated. All enquiries are handled on a strictly confidential basis through the appointed advisory channel.

Learn More